Omniome
Omniome is developing a breakthrough DNA sequencing platform capable of delivering unsurpassed sequencing accuracy with the potential to advance cancer diagnostics, drive high fidelity single-cell applications and broadly support clinical sequencing. Our proprietary scar-free sequencing biochemistry and technology provides enhanced precision and flexibility.
65.8
65.8
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
$ 120.00 M
Funding
$ 120.00 M
Statistics
NA
Ventures > Omniome
Omniome
Active
Action
Omniome is developing a breakthrough DNA sequencing platform capable of delivering unsurpassed sequencing accuracy with the potential to advance cancer diagnostics, drive high fidelity single-cell applications and broadly support clinical sequencing. Our proprietary scar-free sequencing biochemistry and technology provides enhanced precision and flexibility.
- Funding
0and0